Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia

Eur Respir J. 2006 Jun;27(6):1210-6. doi: 10.1183/09031936.06.00139305. Epub 2006 Mar 1.

Abstract

The mortality rate of chronic obstructive pulmonary disease (COPD) patients with community-acquired pneumonia (CAP) is reported to be low. However, studies carried out to date have included <20% of critically ill patients. The current authors performed a secondary analysis of a prospective study evaluating 428 immunocompetent patients admitted to the intensive care unit (ICU) for severe CAP. In total, 176 COPD patients were compared with 252 non-COPD patients. In COPD patients, ICU mortality (odds ratio (OR) 1.58; 95% confidence interval (CI) 1.01-1.43) and mechanical ventilation (OR 2.78; 95% CI 1.63-4.74) rates were higher than in non-COPD patients. The ICU mortality was 39% for COPD patients initially intubated and 50% for those who failed noninvasive ventilation. The proportion of patients who were males, aged >/=70 yrs, smokers and who had chronic heart disease or Pseudomonas aeruginosa were higher in COPD patients. Inappropriate empirical antibiotic therapy was associated with higher mortality (OR 3.8; 95% CI 1.19-12.6). ICU mortality in COPD patients with adequate therapy was associated with bilateral pneumonia (OR 2.32; 95% CI 1.18-4.53) and shock (OR 3.53; 95% CI 1.31-9.71). In conclusion, chronic obstructive pulmonary disease patients hospitalised with community-acquired pneumonia in the intensive care unit had higher mortality and need of mechanical ventilation when compared with patients without chronic obstructive pulmonary disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Cause of Death
  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / mortality*
  • Comorbidity
  • Confidence Intervals
  • Empiricism
  • Female
  • Hospital Mortality
  • Humans
  • Intensive Care Units / statistics & numerical data*
  • Male
  • Middle Aged
  • Odds Ratio
  • Patient Admission / statistics & numerical data*
  • Pneumonia, Bacterial / drug therapy
  • Pneumonia, Bacterial / mortality*
  • Prospective Studies
  • Pseudomonas Infections / mortality
  • Pulmonary Disease, Chronic Obstructive / mortality*
  • Respiration, Artificial / mortality
  • Risk Factors
  • Survival Analysis
  • Treatment Failure

Substances

  • Anti-Bacterial Agents